Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.08T, Eli Lilly(LLY) trades at $1,150.06. The stock has a price-to-earnings ratio of 38.83 and currently yields dividends of 0.59%.
During the trading session on 2026-10-06, Eli Lilly(LLY) shares reached a daily high of $1,165.73 and a low of $1,139.50. At a current price of $1,150.06, the stock is +0.9% higher than the low and still -1.3% under the high.
Trading activity shows a volume of 1.98M, compared to an average daily volume of 2.22M.
The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.
The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.
LLY News
Eli Lilly (LLY) just expanded its collaboration with Gate Bioscience to pursue additional molecular gate therapeutics, a research heavy area that often attracts...
Eli Lilly (LLY +0.02%) is the only healthcare stock in the trillion-dollar club, and for good reason. Its business has been booming due to its successful GLP-1...
The stock of Eli Lilly (LLY) is up about 1% on Oct. 5 after the company secured a regulatory win for one of its experimental cancer drugs called Olomorasib. The...
Analyst ratings
84%
of 32 ratingsMore LLY News
Eli Lilly (LLY) was granted FDA orphan designation for olomorasib for the treatment of pancreatic cancer, according to a post to the agency’s website. Publishe...
The U.S. Food and Drug Administration on Friday approved an additional indication of Jaypirca (pirtobrutinib), enabling Eli Lilly and Co. (NYSE:LLY) to market t...
Is it better to pay a premium for explosive growth or hunt for value in a steady giant? This is the central question for investors choosing between Eli Lilly (L...
Healthcare stocks have lagged broader equities over the past few years, but the company that is now the largest in that sector, Eli Lilly (LLY -0.61%), has deli...
Eli Lilly (LLY -0.61%) has been making the headlines for one particular reason over the last few years. It dominates in an area that has captured the general pu...
Bond yields are rising, inflation remains above the Federal Reserve's target, and there has already been one Fed rate hike. Wall Street is bracing for further r...
Eli Lilly (NYSE:LLY) reported new clinical data on obesity drug Foundayo, diabetes candidate EloraTZP, and dermatitis therapy EBGLYSS, alongside plans for regul...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.